MarketScreener Editorial Features Insmed Incorporated
Equities
INSM
US4576693075
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 146.17 USD | -1.52% |
|
-3.22% | -16.01% |
| 12/02 | Insmed Insider Sold Shares Worth $1,979,764, According to a Recent SEC Filing | MT |
| 28/01 | Barclays Initiates Coverage on Insmed With Overweight Rating, $231 Price Target | MT |
MarketScreener Editorial Features
Search
No results for this search
- Stock Market
- Equities
- INSM Stock
- News Insmed Incorporated
- MarketScreener Editorial Features
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition

























